Anticholinergic Exposure in the German National Cohort (NAKO): Prevalence and Drug Utilization Patterns in Real-World Settings
Background: Anticholinergic drugs inhibit muscarinic acetylcholine receptors and are used to treat a variety of conditions, such as COPD, depression, Parkinson's disease, overactive bladder, and irritable bowel syndrome [ref:1], [ref:2], [ref:3]. At the same time, [for full text, please go to the a.m. URL]
Institutions
- Goethe University Frankfurt (DE)
Publication Details
- Journal
- German Medical Science (German Research Foundation)
- Published
- 2025-11-11
- DOI
- https://doi.org/10.3205/25gaa10
- Primary Topic
- Sleep and related disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00